The content on this site is intended for healthcare professionals only
Prof Folakemi Odedina speaks to ecancer about harnessing AI and data to predict, personalise and transform cancer care.
In this interview, she explores the transformative power of AI and data science in revolutionising cancer care.
She also talks about how Mayo Clinic is pioneering predictive models to detect deadly cancers years in advance, enabling personalised treatments and improved patient outcomes.
Prof Odedina highlights the ethical considerations, data privacy, and the crucial need for diverse representation in AI development for equitable cancer health.
Extended interval tarlatamab dosing shows consistent clinical activity in previously treated SCLC
Therapeutic mammoplasty: An advanced oncoplastic breast surgery technique
Highlights from APCCC 2026
Xaluritamig plus abiraterone shows promising anti-tumour activity with manageable safety in chemotherapy-naïve mCRPC
Screen-detectable cancers account for majority of early-onset cancer cases under age 50
Challenges in high-risk NMIBC: Addressing current unmet needs to optimise patient care
What are the barriers for diverse and inclusive clinical trial recruitment?
Advancing clinical trials in Africa
Addressing cancer control challenges in Africa
